期刊文献+

黄芪注射液对血管紧张素Ⅱ诱导的H9c2心肌细胞凋亡的影响及其机制研究 被引量:8

Effect of Astragalus Injection on AngiotensinⅡ-Induced H9c2 Myocardial Apoptosis and Its Mechanism
下载PDF
导出
摘要 【目的】探讨黄芪注射液对血管紧张素Ⅱ(AngⅡ)诱导的H9c2心肌细胞凋亡的影响及可能机制。【方法】将H9c2心肌细胞分为对照组、AngⅡ组、AngⅡ+黄芪注射液组。以AngⅡ诱导的心肌细胞凋亡为模型。细胞计数试剂盒8(CCK-8)检测细胞活性;流式细胞术测定细胞凋亡情况;三磷酸腺苷(ATP)比色/荧光法检测细胞中ATP含量的变化;钙离子荧光探针(Fura-2AM)法检测细胞内钙离子含量;实时定量聚合酶链反应(RT-PCR)法检测细胞电压依赖性阴离子通道1(VDAC1)、线粒体融合蛋白2(Mfn2)及葡萄糖调节蛋白75(GRP75)基因的表达;蛋白免疫印迹(Western Blot)法检测细胞VDAC1、Mfn2、GRP75的蛋白表达。【结果】与对照组比较,AngⅡ组细胞凋亡率,ATP含量,钙含量,Mfn2、GRP75 mRNA表达水平,VDAC1、Mfn2、GRP75蛋白表达水平升高,VDAC1 m RNA表达水平降低(P<0.05或P<0.01);与AngⅡ组比较,AngⅡ+黄芪注射液组细胞凋亡率,ATP含量,钙含量,Mfn2、GRP75 m RNA表达水平,VDAC1、Mfn2、GRP75蛋白表达水平降低,VDAC1 mRNA表达水平升高(P<0.05或P<0.01)。【结论】黄芪注射液可通过改善心肌细胞能量代谢和线粒体钙离子转运来抑制心肌细胞凋亡,发挥心肌细胞保护作用。 Objective To investigate the effect of Astragalus injection on the angiotensinⅡ-induced H9c2myocardial apoptosis and its possible mechanism.Methods H9c2 cardiomyocytes were divided into control group,AngⅡgroup and AngⅡ+Astragalus injection group.Myocardial apoptosis induced by AngⅡwas used as a model.Cell activity was determined by cell counting kit-8(CCK-8);cell apoptosis was determined by flow cytometry(FCM);adenosine triphosphate(ATP)content was detected by colorimetric/fluorescence assay;intracellular calcium ion content was detected by calcium fluorescence probe(Fura-2AM).The expression of voltage-dependent anionic channel 1(VDAC1),mitochondrial fusion protein 2(Mfn2)and glucose regulatory protein 75(GRP75)genes were detected by real-time quantitative polymerase chain reaction(RT-PCR).The protein expression of VDAC1,Mfn2 and GRP75 were detected by Western Blot.Results Compared with the control group,the apoptosis rate,ATP content,calcium content,Mfn2 and GRP75 mRNA expression levels,and VDAC1,Mfn2and GRP75 protein expression levels were increased and VDAC1 mRNA level was decreased in the AngⅡgroup(P<0.05 or P<0.01).Compared with the AngⅡgroup,the apoptosis rate,ATP content,calcium content,Mfn2 and GRP75 mRNA expression levels,and VDAC1,Mfn2 and GRP75 protein expression levels were decreased,and VDAC1 mRNA expression level was increased in AngⅡ+Astragalus injection group(P<0.05 or P<0.01).Conclusion Astragalus injection is able to inhibit the myocardial apoptosis by improving the energy metabolism and mitochondrial calcium ion transport.
作者 柯双桥 张婷 庞瑞明 KE Shuang-Qiao;ZHANG Ting;PANG Rui-Ming(Bao’an Traditional Chinese Medicine Hospital Affiliated to Guangzhou University of Chinese Medicine,Shenzhen 518000 Guangdong,China;Dongzhimen Hospital of Beijing University of Chinese Medicine,Beijing 100000,China)
出处 《广州中医药大学学报》 CAS 2022年第4期914-919,共6页 Journal of Guangzhou University of Traditional Chinese Medicine
关键词 黄芪注射液 充血性心力衰竭 血管紧张素Ⅱ 细胞凋亡 线粒体钙转运 能量代谢 心肌细胞 Astragalus injection congestive heart-failure(CHF) AngiotensinⅡ cell apoptosis mitochondrial calcium transport energy metabolism myocardial cells
  • 相关文献

参考文献5

二级参考文献45

  • 1俞志军.分析小剂量瑞舒伐他汀对老年慢性心力衰竭合并心房颤动患者改善心功能及预防房颤复发的作用[J].医药界,2020,0(3):0030-0030. 被引量:3
  • 2李绍敏.补肾法治疗充血性心衰及与益气法的对比研究[J].实用中医内科杂志,2005,19(5):480-480. 被引量:5
  • 3李立志.陈可冀治疗充血性心力衰竭经验[J].中西医结合心脑血管病杂志,2006,4(2):136-138. 被引量:189
  • 4林齐鸣.试论心与水液代谢的关系[J].四川中医,1996,14(11):1-2. 被引量:6
  • 5Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACC/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline[J]. JAm Cardiol, 2013, 62(16): e147-e239.
  • 6McMurray JJ, Adarnopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology in collaboration with the Heart Failure Association(HFA) of the ESC[J]. Eur Heart, 2012, 33(14): 1787-1847.
  • 7Kinugawa K, Sato N, Inomata T, et al. Efficacy and safety of tolvaptan in heart failure patients with volume overload[J]. Cite J, 2014, 78(4): 844-852.
  • 8Effect of metoprolol CR/XL in chronic heart failure: metoprolol CRfXL mandomised intervention trial in congestive heart fallure(MERIT-HF)[J]. Lancet, 1999, 353: 2001-2007.
  • 9The cardiac insufficiency bisoprolol study II(CIBIS-ID: a randomised trial[J]. Lancet, 1999, 353: 9-13.
  • 10Packer M, Fowler MB, Roecker EB, et al. Effect of earvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study[J]. Circulation, 2002, 106: 2194-2199.

共引文献34

同被引文献150

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部